Format

Send to

Choose Destination
Lung. 2020 Jan 2. doi: 10.1007/s00408-019-00299-0. [Epub ahead of print]

Circulating P-Selectin Glycoprotein Ligand 1 and P-Selectin Levels in Obstructive Sleep Apnea Patients.

Author information

1
Department of Pulmonology, Semmelweis University, Tömő utca 25-29, Budapest, Hungary. horvath.peter2@med.semmelweis-univ.hu.
2
Department of Pulmonology, Semmelweis University, Tömő utca 25-29, Budapest, Hungary.
3
Department of Radiology, Semmelweis University, Budapest, Hungary.

Abstract

PURPOSE:

Obstructive sleep apnea (OSA) is characterized by chronic intermittent hypoxia which induces inflammation in blood vessels leading to the development of cardiovascular comorbidities. Several studies implicated the role of P-selectin in vascular inflammation of OSA. P-selectin glycoprotein ligand 1 (PSGL-1) is the main activator for P-selectin and is involved in immune cell trafficking. However, PSGL-1 has not been analyzed in OSA. The aim of the study was to investigate plasma PSGL-1 and P-selectin levels to have a deeper understanding on their interaction in obstructive sleep apnea.

METHODS:

Fifty-one untreated patients with OSA and 42 non-OSA controls were recruited. Plasma PSGL-1 levels were determined in evening and morning samples, P-selectin levels were analyzed in morning samples using commercially available ELISA kits. Polysomnography was performed in all participants. OSA was defined by an apnea-hypopnea index ≥ 5/h.

RESULTS:

PSGL-1 levels did not differ between controls and OSA patients either in the evening or in the morning. Although, there was no difference between controls (16.9/6.8-40.8 ng/ml) and patients with OSA (19.6/8.4-56.8, p = 0.24), patients with severe OSA had increased plasma P-selectin levels (25.6/8.4-56.8 ng/ml) compared to mild OSA patients (14.1/8.5-35.3 ng/ml, p = 0.006) and controls (p = 0.03).

CONCLUSIONS:

P-selectin expression relates to disease severity suggesting a pathophysiological role in endothelial cell activation. PSGL-1 levels are unaltered in OSA, suggesting an alternative activation pathway for P-selectin in OSA.

KEYWORDS:

Adhesion molecules; Comorbidities; Sleep apnea; Systemic inflammation

PMID:
31897593
DOI:
10.1007/s00408-019-00299-0

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center